FDA has issued Revision 1 of the Q&A for ICH E14 on Human TQT Studies FDA has issued the Revision 1 of the Q&A for ICH E14 on Human TQT Studies this week. Posted on the FDA website week of 15 October 2012 editor2012-10-21T19:01:25+00:0017.10.2012|Drug Development Strategy, Pharmacovigilance| Comparta esta información, escoja su plataforma FacebookTwitterLinkedInEmail
